157 related articles for article (PubMed ID: 16621244)
1. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Sun M; Xu X; Lu Q; Pan Q; Hu X
Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
[TBL] [Abstract][Full Text] [Related]
2. Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
Li L; Pan Q; Sun M; Lu Q; Hu X
Life Sci; 2007 Jan; 80(8):741-8. PubMed ID: 17129588
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
4. Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
Pan Q; Lu Q; Zhang K; Hu X
Cancer Chemother Pharmacol; 2006 Jul; 58(1):99-106. PubMed ID: 16231181
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
Matsunaga S; Asano T; Tsutsuda-Asano A; Fukunaga Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):348-53. PubMed ID: 16331495
[TBL] [Abstract][Full Text] [Related]
6. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B--a novel inhibitor of P-glycoprotein.
Qiangrong P; Wang T; Lu Q; Hu X
Biochem Biophys Res Commun; 2005 Sep; 335(2):406-11. PubMed ID: 16084496
[TBL] [Abstract][Full Text] [Related]
8. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells.
Li L; Lu Q; Shen Y; Hu X
Biochem Pharmacol; 2006 Feb; 71(5):584-95. PubMed ID: 16405922
[TBL] [Abstract][Full Text] [Related]
9. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
[TBL] [Abstract][Full Text] [Related]
10. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
Janneh O; Jones E; Chandler B; Owen A; Khoo SH
J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
[TBL] [Abstract][Full Text] [Related]
12. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin.
Chauvier D; Kegelaer G; Morjani H; Manfait M
J Pharm Sci; 2002 Aug; 91(8):1765-75. PubMed ID: 12115804
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.
Nabekura T; Yamaki T; Ueno K; Kitagawa S
Cancer Chemother Pharmacol; 2008 Oct; 62(5):867-73. PubMed ID: 18204840
[TBL] [Abstract][Full Text] [Related]
16. Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates.
Pec MK; Aguirre A; Fernández JJ; Souto ML; Dorta JF; Villar J
Int J Mol Med; 2002 Nov; 10(5):605-8. PubMed ID: 12373300
[TBL] [Abstract][Full Text] [Related]
17. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship.
Slaninová I; Brezinová L; Koubíková L; Slanina J
Toxicol In Vitro; 2009 Sep; 23(6):1047-54. PubMed ID: 19531378
[TBL] [Abstract][Full Text] [Related]
18. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
20. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
